Skip to main content

Loading market ticker...

Laurus Labs

Healthcare NSE:LAURUSLABS

1042.90INR
4.10 ( 0.39%)

Last update at April 2, 2026, midnight

Day Range

994.251049.80
LowHigh

52 Week Range

500.05 1141.00
LowHigh

Fundamentals

  • Previous Close 1038.80
  • Market Cap 594328.09M
  • Volume2,919,766
  • P/E Ratio 87.10
  • EBITDA 14700.50M
  • Revenue TTM 63583.90M
  • Revenue Per Share TTM 117.85
  • Gross Profit TTM 35540.40M
  • Diluted EPS TTM 12.64

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 4882.20M 2304.20M 11089.40M 10838.50M 13011.10M
Net income 3583.20M 1605.50M 7901.10M 8275.20M 9835.80M
Total Revenue 55539.60M 50408.30M 60405.50M 48885.40M 47232.20M
Gross Profit 30759.80M 25027.10M 31735.10M 26402.20M 25258.50M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 93355.70M 83870.30M 76604.00M 69680.40M 57506.90M
Intangible assets 193.20M 190.20M 129.30M 108.30M 93.20M
Other current assets 2106.50M 1527.10M 1306.90M 11.20M 9.80M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -394.00M 932.70M -296.80M 268.90M 467.70M
Operating Cash 6016.50M 6656.90M 9939.00M 9111.00M 7330.00M
Free Cash Flow -393.50M -126.20M 37.40M 342.60M 442.30M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
LAURUSLABS
Laurus Labs 		4.10 0.39% 1042.90 594328.09 87.10
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-34.90 -2.02% 1693.60 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-50.00 -0.85% 5856.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-124.10 -3.02% 3987.20 1362716.66 63.48
CIPLA
Cipla Limited 		-3.50 -0.29% 1192.40 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.